Anteris Technologies Ltd has 3D single-piece Transcatheter H

Anteris Technologies has 3D single-piece Transcatheter Heart Valve DurAVR™ featured during TVT 2021
CEO Wayne Paterson said: “Having DurAVR™ recognized at this very important meeting is a clear demonstration of support for our potential within the Structural Heart Faculty.”
DurAVR™ was also recognised by founder and chairman emeritus of the Cardiovascular Research Foundation.
Anteris Technologies Ltd (ASX:AVR, OTCQB:AMEUF, FRA:DDF) has had its unique 3D single-piece Transcatheter Heart Valve DurAVR™ featured in the innovation section of the Transcatheter Valve Therapies Structural Heart Summit (TVT 2021).
DurAVR™ was also recognised by the founder and chairman emeritus of the Cardiovascular Research Foundation (CRF), which sponsors TVT 2021.

Related Keywords

Wayne Paterson , Minneapolis Heart Institute , Columbia University Professor Of Cardiology , Cardiovascular Research Foundation , Transcatheter Heart Valve , Left Atrial Appendage , Structural Heart Faculty , Heart Summit , Medical Advisory Board , Abbott Northwestern Hospital , Paul Sorajja , Aortic Valve Replacement , Columbia University , Interventional Vascular Therapy , Aortic Stenosis , வேன் பேட்டர்சன் , மினியாபோலிஸ் இதயம் நிறுவனம் , இருதய ஆராய்ச்சி அடித்தளம் , இதயம் உச்சிமாநாடு , அப்போட் வடமேற்கு மருத்துவமனை , பெருநாடி அடைப்பான் மாற்று , கொலம்பியா பல்கலைக்கழகம் , தலையீடு வாஸ்குலர் சிகிச்சை , பெருநாடி ஸ்டெனோசிஸ் ,